These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23195033)

  • 1. A higher maternal choline intake among third-trimester pregnant women lowers placental and circulating concentrations of the antiangiogenic factor fms-like tyrosine kinase-1 (sFLT1).
    Jiang X; Bar HY; Yan J; Jones S; Brannon PM; West AA; Perry CA; Ganti A; Pressman E; Devapatla S; Vermeylen F; Wells MT; Caudill MA
    FASEB J; 2013 Mar; 27(3):1245-53. PubMed ID: 23195033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choline inadequacy impairs trophoblast function and vascularization in cultured human placental trophoblasts.
    Jiang X; Jones S; Andrew BY; Ganti A; Malysheva OV; Giallourou N; Brannon PM; Roberson MS; Caudill MA
    J Cell Physiol; 2014 Aug; 229(8):1016-27. PubMed ID: 24647919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia.
    Sela S; Itin A; Natanson-Yaron S; Greenfield C; Goldman-Wohl D; Yagel S; Keshet E
    Circ Res; 2008 Jun; 102(12):1566-74. PubMed ID: 18515749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trophoblast expression of fms-like tyrosine kinase 1 is not required for the establishment of the maternal-fetal interface in the mouse placenta.
    Hirashima M; Lu Y; Byers L; Rossant J
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15637-42. PubMed ID: 14668430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia.
    Rajakumar A; Cerdeira AS; Rana S; Zsengeller Z; Edmunds L; Jeyabalan A; Hubel CA; Stillman IE; Parikh SM; Karumanchi SA
    Hypertension; 2012 Feb; 59(2):256-64. PubMed ID: 22215706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia.
    Rana S; Karumanchi SA; Levine RJ; Venkatesha S; Rauh-Hain JA; Tamez H; Thadhani R
    Hypertension; 2007 Jul; 50(1):137-42. PubMed ID: 17515455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.
    Rajakumar A; Michael HM; Rajakumar PA; Shibata E; Hubel CA; Karumanchi SA; Thadhani R; Wolf M; Harger G; Markovic N
    Placenta; 2005 Aug; 26(7):563-73. PubMed ID: 15993706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia.
    Powers RW; Roberts JM; Cooper KM; Gallaher MJ; Frank MP; Harger GF; Ness RB
    Am J Obstet Gynecol; 2005 Jul; 193(1):185-91. PubMed ID: 16021077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women.
    Levine RJ; Qian C; Maynard SE; Yu KF; Epstein FH; Karumanchi SA
    Am J Obstet Gynecol; 2006 Apr; 194(4):1034-41. PubMed ID: 16580293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of calcium transport channels in placenta primary cells and tissues derived from preeclamptic placenta.
    Yang H; Kim TH; An BS; Choi KC; Lee HH; Kim JM; Jeung EB
    Mol Cell Endocrinol; 2013 Mar; 367(1-2):21-30. PubMed ID: 23267838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia.
    Staff AC; Braekke K; Harsem NK; Lyberg T; Holthe MR
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):33-9. PubMed ID: 15935542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum placental growth factor and soluble fms-like tyrosine kinase 1 as early predictors of preeclampsia.
    Shokry M; Bedaiwy MA; Fathalla MM; Alsemary A; Elwakil S; Murphy A
    Acta Obstet Gynecol Scand; 2010; 89(1):143-6. PubMed ID: 20021269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble and membranous vascular endothelial growth factor receptor-1 in pregnancies complicated by pre-eclampsia.
    Tripathi R; Rath G; Jain A; Salhan S
    Ann Anat; 2008 Nov; 190(5):477-89. PubMed ID: 18992679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Predictive value of serum soluble fms-like tyrosine kinase 1 concentration in preeclampsia at second trimester].
    Ye YH; Liu L; Zhan Y; Peng W
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):433-5. PubMed ID: 17083803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum soluble fms-like tyrosine kinase 1 (sFlt1) level in women with hydatidiform mole.
    Koga K; Osuga Y; Tajima T; Hirota Y; Igarashi T; Fujii T; Yano T; Taketani Y
    Fertil Steril; 2010 Jun; 94(1):305-8. PubMed ID: 19269632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Concentrations of antiangiogenic factors, triglycerides, glucose and insulin in women with two types of preeclampsia].
    Kornacki J; Wirstlein P; Skrzypczak J
    Ginekol Pol; 2013 Sep; 84(9):770-5. PubMed ID: 24191515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and significance of soluble fms-like tyrosine kinase 1 in preeclampsia placenta].
    Ye YH; Liu L; Zhan Y; Peng W
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):521-4. PubMed ID: 17083834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis in gestational vascular complications.
    Yagel S
    Thromb Res; 2011 Feb; 127 Suppl 3():S64-6. PubMed ID: 21262445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia.
    Kim YN; Lee DS; Jeong DH; Sung MS; Kim KT
    Prenat Diagn; 2009 May; 29(5):464-70. PubMed ID: 19242927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia.
    Stepan H; Faber R; Wessel N; Wallukat G; Schultheiss HP; Walther T
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2424-7. PubMed ID: 16569734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.